Clinical trial
Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of…
NCT00236080 · Cephalon, Industry · Completed
Key facts
| NCT number | NCT00236080 |
|---|---|
| Title | Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil (150, 200, and 250 mg) and PROVIGIL® (200 mg) in Patients With Chronic Shift Work Sleep Disorder |
| Lead sponsor | Cephalon, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Shift Work Sleep Disorder |
| Intervention type | Drug |
| Interventions | PROVIGIL 200 mg, Armodafinil 250 mg, Armodafinil 200 mg, Armodafinil 150 mg, Placebo |
| Enrollment | 136 |
| Start date | Aug 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Oct 12, 2005 |
| Last update posted | Jul 19, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: